Neurocrine Biosciences, Inc. Insider Transactions
Neurocrine Biosciences, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
ABERNETHY MATT
CFO |
Sell | 1,206 @ $116.87 | $140.94 K | 35,810 | 02/13/2025 | 02/14/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 755 @ $116.80 | $88.18 K | 20,190 | 02/13/2025 | 02/14/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 796 @ $116.77 | $92.95 K | 19,544 | 02/13/2025 | 02/14/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 1,352 @ $116.85 | $157.98 K | 34,775 | 02/13/2025 | 02/14/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 3,012 @ $116.68 | $351.45 K | 524,209 | 02/13/2025 | 02/14/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 2,832 @ $116.69 | $330.47 K | 521,618 | 02/13/2025 | 02/14/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 1,098 @ $116.74 | $128.18 K | 43,784 | 02/13/2025 | 02/14/2025 | |
|
SHERWIN STEPHEN A
Director |
Sell | 13,831 @ $116.69 | $1.61 M | 10,673 | 02/13/2025 | 02/14/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 1,056 @ $116.71 | $123.25 K | 44,689 | 02/13/2025 | 02/14/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 604 @ $116.74 | $70.51 K | 34,768 | 02/13/2025 | 02/14/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 700 @ $118.31 | $82.82 K | 1,998 | 02/10/2025 | 02/12/2025 | |
|
Cooke Julie
Chief Human Resources Officer |
Sell | 700 @ $118.28 | $82.79 K | 18,831 | 02/10/2025 | 02/12/2025 | |
|
ROBERTS EIRY
Chief Medical Officer |
Sell | 980 @ $118.22 | $115.85 K | 33,253 | 02/10/2025 | 02/12/2025 | |
|
GORMAN KEVIN CHARLES
Director |
Sell | 2,274 @ $118.37 | $269.17 K | 519,074 | 02/10/2025 | 02/12/2025 | |
|
BENEVICH ERIC
Chief Commercial Officer |
Sell | 980 @ $118.31 | $115.94 K | 42,799 | 02/10/2025 | 02/12/2025 | |
|
Lippoldt Darin
Chief Legal Officer |
Sell | 911 @ $118.25 | $107.73 K | 41,679 | 02/10/2025 | 02/12/2025 | |
|
ABERNETHY MATT
CFO |
Sell | 980 @ $118.27 | $115.91 K | 33,561 | 02/10/2025 | 02/12/2025 | |
|
Gano Kyle
CEO |
Sell | 980 @ $118.39 | $116.02 K | 137,658 | 02/10/2025 | 02/12/2025 | |
|
Delaet Ingrid
Chief Regulatory Officer |
Sell | 623 @ $149.29 | $93.01 K | 3,442 | 02/03/2025 | 02/04/2025 | |
|
Boyer David W.
Chief Corp. Affairs Officer |
Sell | 1,104 @ $152.94 | $168.85 K | 1,369 | 01/31/2025 | 02/04/2025 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Neurocrine Biosciences, Inc. FAQ's
The list of insiders at Neurocrine Biosciences, Inc. includes RASTETTER WILLIAM H, GORMAN KEVIN CHARLES, Onyia Jude, Delaet Ingrid, Gano Kyle.
Insiders have sold a total of 244.87 K Neurocrine Biosciences, Inc. shares in the last 12 months for a total of 31.19 M sold.
The following insiders have sold Neurocrine Biosciences, Inc. shares in the last 12 months: RASTETTER WILLIAM H ($6.04 M), GORMAN KEVIN CHARLES ($14.60 M), Onyia Jude ($10.45 M), Delaet Ingrid ($61.70 K), Gano Kyle ($42.59 K),
The list of congress members trading at Neurocrine Biosciences, Inc. includes Michael McCaul.